Literature DB >> 28116470

[Obeticholic acid in primary biliary cholangitis : PBC OCA international study of efficacy (POISE)].

G Gerken1, S Nitschmann2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28116470     DOI： 10.1007/s00108-016-0185-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  2 in total

1.  A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.

Authors:  Frederik Nevens; Pietro Andreone; Giuseppe Mazzella; Simone I Strasser; Christopher Bowlus; Pietro Invernizzi; Joost P H Drenth; Paul J Pockros; Jaroslaw Regula; Ulrich Beuers; Michael Trauner; David E Jones; Annarosa Floreani; Simon Hohenester; Velimir Luketic; Mitchell Shiffman; Karel J van Erpecum; Victor Vargas; Catherine Vincent; Gideon M Hirschfield; Hemant Shah; Bettina Hansen; Keith D Lindor; Hanns-Ulrich Marschall; Kris V Kowdley; Roya Hooshmand-Rad; Tonya Marmon; Shawn Sheeron; Richard Pencek; Leigh MacConell; Mark Pruzanski; David Shapiro
Journal:  N Engl J Med       Date:  2016-08-18       Impact factor: 91.245

Review 2.  Obeticholic acid for the treatment of primary biliary cirrhosis.

Authors:  Palak J Trivedi; Gideon M Hirschfield; M Eric Gershwin
Journal:  Expert Rev Clin Pharmacol       Date:  2015-11-07       Impact factor: 5.045
  2 in total
  2 in total

Review 1.  Treatment of Dyslipidemia in Common Liver Diseases.

Authors:  Elizabeth K Speliotes; Maya Balakrishnan; Lawrence S Friedman; Kathleen E Corey
Journal:  Clin Gastroenterol Hepatol       Date:  2018-04-21       Impact factor: 11.382

Review 2.  Novel strategies and therapeutic options for the management of primary biliary cholangitis.

Authors:  Amardeep Khanna; David E Jones
Journal:  Therap Adv Gastroenterol       Date:  2017-09-07       Impact factor: 4.409
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.